Endometriosis is a chronic inflammatory disease in which tissue resembling the uterine lining grows in places it does not belong, from the ovaries and pelvic walls to, in rarer cases, the lungs and diaphragm. Roughly one in ten women of reproductive age has it, yet the average time from first symptoms to diagnosis in the United States sits at about four and a half years. That delay exists in part because the condition is widely misunderstood as simply “bad periods.” In reality, endometriosis is a systemic disease involving immune dysfunction, hormonal resistance, nerve rewiring, and connections to conditions most people would never associate with the uterus.
What Happens Inside the Body
In a healthy menstrual cycle, the endometrium thickens inside the uterus and sheds during a period. In endometriosis, tissue that behaves like endometrium establishes itself outside the uterine cavity. These displaced patches still respond to hormonal signals, cycling through growth and attempted shedding, but with no exit route. The result is local inflammation, scarring, and the formation of adhesions that can bind organs together. The disease is estrogen-dependent, meaning estrogen fuels lesion growth, while the normal counterbalance from progesterone is weakened. Researchers describe this hormonal imbalance as “progesterone resistance,” where the tissue’s ability to respond to progesterone signaling is compromised by chronic inflammation, altered gene expression, and epigenetic changes.1PubMed Central. Progesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms
How endometrial-like tissue ends up in the wrong locations in the first place has been debated for over a century. The most cited explanation is retrograde menstruation, where menstrual blood flows backward through the fallopian tubes into the pelvic cavity. But that happens in most women who menstruate, and only a fraction develop endometriosis, so retrograde flow alone cannot be the full story. Other proposed pathways include immune dysregulation that fails to clear misplaced cells, transformation of peritoneal cells into endometrial-like tissue (called coelomic metaplasia), involvement of stem cells, and epigenetic alterations.2PubMed Central. The Main Theories on the Pathogenesis of Endometriosis The honest answer is that the true cause remains poorly understood, and the disease probably arises through a combination of these mechanisms rather than any single one.
Three Distinct Subtypes
Not all endometriosis looks or behaves the same. Clinicians generally recognize three subtypes, each with different implications for symptoms and treatment. Superficial peritoneal endometriosis consists of shallow lesions on the lining of the pelvic cavity and tends to have the most well-differentiated tissue pattern. Ovarian endometriomas, sometimes called “chocolate cysts” for their dark fluid content, form on or inside the ovaries. Deep infiltrating endometriosis penetrates more than five millimeters below the peritoneal surface and can invade the bowel wall, bladder, or the tissue between the rectum and vagina.3PubMed Central. Three Types of Endometriosis: Pathogenesis, Diagnosis and Treatment. State of the Art.
The subtypes matter clinically. Research has shown that very deep implants were found exclusively in patients with pain, whereas superficial implants were found most frequently in patients whose primary concern was infertility.4PubMed. Deeply infiltrating pelvic endometriosis: histology and clinical significance This is one reason two people with endometriosis can have wildly different experiences: one might have debilitating daily pain, while another discovers the disease only after difficulty conceiving.
Why the Pain Goes Far Beyond Cramps
The popular image of endometriosis pain is a worse-than-usual period cramp, but that framing misses most of what the disease actually does to the nervous system. Endometriosis lesions do not just sit passively. They actively secrete cytokines, growth factors, and nerve growth factors that stimulate nerve fiber proliferation in and around the lesions themselves.5PubMed Central. Endometriosis-Related Chronic Pelvic Pain In other words, the disease literally grows its own nerve supply, creating new pain pathways where none existed before.
This matters because over time, the repeated barrage of pain signals rewires how the nervous system processes pain. Peripheral nerves near the lesions become hypersensitive, firing at lower thresholds than normal. Then the central nervous system itself adapts, amplifying incoming signals so that even mild stimuli can register as painful. This process, called central sensitization, can eventually sustain pain independently of lesion activity. Some patients continue to experience significant pain even after lesions are surgically removed, because the nervous system has been fundamentally altered.6PubMed. Endometriosis-associated Pain: Mechanism, Neuroimmune Signature, and Translational Precision Strategies This is why telling someone with endometriosis that their pain is “just in their head” is both scientifically wrong and particularly harmful: the pain is real, measurable, and rooted in physical changes to nerve tissue.
The Immune System’s Role
A healthy immune response would recognize endometrial cells in the wrong location and clear them out. In people with endometriosis, that cleanup fails. Macrophages, the immune cells normally responsible for engulfing and destroying debris, are present in endometriosis lesions in large numbers, but they behave abnormally. Rather than destroying misplaced tissue, these macrophages adopt an altered state and secrete signals that promote inflammation, blood vessel growth, nerve development, and scar tissue formation.7PubMed Central. Macrophages in endometriosis: key roles and emerging therapeutic opportunities-a narrative review
Research into the underlying immune dynamics has found that certain inflammatory molecules actively suppress the macrophages’ ability to eat and destroy ectopic tissue. When concentrations of the signaling molecule IL-33 rise, macrophages shift toward an anti-inflammatory profile and lose their phagocytic ability, meaning they can no longer clear the tissue that should not be there.8Journal of Endometriosis and Uterine Disorders. Immune and endocrine regulation in endometriosis: what we know Deep immunophenotyping studies have confirmed this pattern, showing that endometrial macrophages in people with endometriosis display a more inflammatory phenotype paired with decreased ability to clear cells, consistent with the idea that defective immune surveillance is not just a bystander but a driver of the disease.9PubMed Central. Deep immunophenotyping reveals endometriosis is marked by dysregulation of the mononuclear phagocytic system in endometrium and peripheral blood
The Gut Symptom Problem
Bloating, painful bowel movements, constipation, and diarrhea are among the most common endometriosis complaints, and they’re also the primary reason the disease gets confused with irritable bowel syndrome. A meta-analysis of the overlap found that women with endometriosis had roughly three times the odds of also having IBS compared to women without the condition.10PubMed. Endometriosis and irritable bowel syndrome: a systematic review and meta-analysis But the relationship is more complicated than coincidence. The two conditions share chronic inflammation, and endometriosis can actually mimic the tissue-level changes seen in IBS, not just the surface symptoms.11PubMed Central. Implication of the enteric glia in the IBS-like colonic inflammation associated with endometriosis
This overlap is a significant contributor to diagnostic delay. A person showing up at a doctor’s office with bloating, irregular bowel habits, and abdominal pain may receive an IBS diagnosis and spend years managing symptoms that never fully resolve because the underlying endometriosis remains untreated. The lesson here is that endometriosis needs to be considered in people with chronic GI symptoms that track with the menstrual cycle, even when there is no obvious “gynecological” complaint.
When Endometriosis Leaves the Pelvis
Most endometriosis lives in the pelvic cavity, but the disease can appear in strikingly distant locations. Thoracic endometriosis syndrome is a recognized entity in which endometrial-like tissue affects the diaphragm, pleural surfaces, or lung tissue. It can cause pneumothorax (a collapsed lung), hemothorax (blood collecting in the chest cavity), coughing up blood, and pulmonary nodules, all timed to the menstrual cycle.12PubMed Central. Thoracic Endometriosis Syndrome: A Review of Diagnosis and Management Catamenial pneumothorax, where a lung collapses around the time of menstruation, is the most common presentation. Some cases are discovered incidentally during pelvic surgery when surgeons notice lesions on the diaphragm in patients who had no chest symptoms at all.13PubMed Central. Thoracic and diaphragmatic endometriosis: Single-institution experience using novel, broadened diagnostic criteria
Endometriosis has also been documented in the abdominal wall (particularly in surgical scars), the umbilicus, and the groin. Scar endometriosis after cesarean sections or other abdominal surgeries is a well-known variant, and even spontaneous abdominal wall disease occurs without prior surgery. Surgical removal tends to work well for abdominal wall lesions, while thoracic disease often requires a combination of surgery and long-term hormonal therapy.14PubMed Central. Extra-pelvic endometriosis: A review
How It Affects Fertility
Roughly a third to half of people with endometriosis experience difficulty conceiving. The mechanisms are multiple and interconnected. Endometriosis disrupts ovarian function, tubal function, and the uterus’s ability to accept an embryo. In the ovary, the disease does not usually damage eggs directly but rather impairs the granulosa cells surrounding them, the cells responsible for nurturing egg development. Inflammation, oxidative stress, disrupted hormone production, and abnormal energy metabolism in these support cells lead to poorer egg quality overall.15PubMed Central. Decreased oocyte quality in patients with endometriosis is closely related to abnormal granulosa cells
Beyond the ovary, the inflammatory environment of the peritoneal cavity can interfere with sperm transport and fertilization, while changes to the uterine lining reduce its receptivity to implantation.16PubMed. Pathogenic mechanisms in endometriosis-associated infertility For people with endometriosis trying to conceive, the path forward often depends on the subtype and severity. Mild disease may respond to surgical treatment of lesions, while more advanced cases frequently benefit from assisted reproductive technologies like IVF.
The Diagnostic Gap
One of the most frustrating aspects of endometriosis is how long it takes to get a diagnosis. In the United States, the mean time from symptom onset to diagnosis is about four and a half years, with the majority of diagnoses made by gynecologists. About half of diagnoses are now made without surgery, through imaging and clinical assessment, while the other half still require a surgical procedure for confirmation.17PubMed. Factors Associated with Time to Endometriosis Diagnosis in the United States
Non-invasive tools like ultrasound and MRI have gotten better at detecting endometriomas and deep infiltrating disease, but they still struggle with superficial peritoneal lesions, the most common subtype. These flat, scattered patches on the peritoneal surface are often invisible to imaging, which means a normal ultrasound does not rule out endometriosis.18PubMed. Strengths and limitations of diagnostic tools for endometriosis and relevance in diagnostic test accuracy research This is a critical point that many patients are not told: being told “your scan looks fine” is not the same as being told you do not have endometriosis.
Emerging research into saliva-based microRNA signatures offers a potential way around this problem. One study identified a panel of 109 salivary microRNAs that could detect endometriosis with very high accuracy in the study population.19PubMed Central. Salivary MicroRNA Signature for Diagnosis of Endometriosis A follow-up study found that a similar approach could identify even the superficial peritoneal subtype specifically.20PubMed. Saliva-based microRNA diagnostic signature for the superficial peritoneal endometriosis phenotype These are early-stage results that need large-scale validation, but the concept of a simple saliva test replacing diagnostic surgery is being actively pursued.
Genetics, Epigenetics, and Environmental Exposure
Endometriosis runs in families. Having a first-degree relative with the disease substantially increases your risk, and researchers have identified numerous gene regions associated with susceptibility. But no single “endometriosis gene” has emerged. The current leading framework proposes a combined genetic and epigenetic mechanism: a person inherits a set of predisposing genetic and epigenetic variations at birth that create vulnerability, and then additional molecular events are needed for actual lesions to develop.21PubMed. Pathogenesis of endometriosis: the genetic/epigenetic theory This helps explain why the disease manifests so differently across individuals even within the same family.
Environmental exposures add another layer. Because endometriosis is estrogen-driven, chemicals that mimic or amplify estrogen’s effects have come under scrutiny. Phthalates, found widely in plastics, personal care products, and food packaging, can bind to estrogen receptors and activate signaling pathways that promote inflammation, tissue invasion, and oxidative stress in endometrial cells. A growing body of evidence points to a clear association between phthalate exposure and endometriosis risk.22PubMed Central. Association between the Exposure to Phthalates and the Risk of Endometriosis: An Updated Review This does not mean phthalates cause endometriosis on their own, but in someone with genetic susceptibility, environmental estrogen disruptors could plausibly tip the balance.
Connections to Autoimmune Disease
People with endometriosis are diagnosed with autoimmune conditions at higher rates than the general population. A large case-control study found that compared to matched controls, patients with endometriosis had increased odds of being diagnosed with rheumatoid arthritis, Hashimoto’s thyroiditis, lupus, multiple sclerosis, pernicious anemia, Sjögren’s syndrome, and myositis within two years of their endometriosis diagnosis. Overall, the odds of having at least one autoimmune condition were roughly twice as high in people with endometriosis.23npj women’s health. Endometriosis and autoimmunity: a large-scale case-control study of endometriosis and 10 distinct autoimmune diseases
Whether this reflects shared underlying immune dysfunction, common genetic vulnerability, or simply increased medical scrutiny once one diagnosis is made remains an open question. But the association is strong enough that clinicians are increasingly encouraged to consider autoimmune screening in endometriosis patients who present with fatigue, joint pain, or other symptoms that do not fit neatly into the endometriosis box.
Treatment Options and Their Trade-Offs
There is no cure for endometriosis. Treatment aims to manage pain, preserve fertility, and slow disease progression. The two main approaches are hormonal suppression and surgery, often used in combination.
Hormonal treatments work by reducing estrogen levels or blocking estrogen’s effects on lesions. Older options include combined oral contraceptives and progestins. A newer class, oral GnRH antagonists, suppresses estrogen production more precisely. These drugs often require “add-back therapy,” small doses of estrogen and progestin given alongside the antagonist to prevent menopausal side effects like hot flushes and bone density loss. The goal is to keep estrogen in a sweet spot: low enough to quiet the disease, high enough to protect bones and quality of life.24PubMed Central. Oral GnRH Antagonists in Combination with Estradiol and Norethindrone Acetate for Pain Relief Associated with Endometriosis Higher doses of these antagonists provide stronger pain relief but carry greater bone density risk, making add-back therapy essential at higher dosing.25PubMed Central. Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Endometriosis: Advances in Research
Surgery aims to remove visible disease. For ovarian endometriomas, excision of the cyst wall outperforms simple drainage or ablation of the cyst lining. A Cochrane review found that excision was associated with significantly lower recurrence of painful periods, pain during sex, and non-menstrual pelvic pain, along with a five-fold increase in spontaneous pregnancy rates in women with prior subfertility compared to ablation.26Cochrane Database of Systematic Reviews. Excisional surgery versus ablative surgery for ovarian endometriomata For minimal to mild disease, though, the picture is less clear. A meta-analysis comparing excision to ablation for superficial lesions found no significant difference in pain improvement at twelve months for any pain type measured.27PubMed. Excision versus Ablation for Management of Minimal to Mild Endometriosis: A Systematic Review and Meta-analysis The surgical approach, in other words, matters most when the disease is advanced.
The Psychological Burden
Years of undiagnosed pain, dismissed symptoms, and disrupted daily life take a toll that extends well beyond the physical. Women with endometriosis report significantly elevated rates of anxiety, depression, and social isolation.28PubMed Central. Psychological Distress and Quality of Life in Women With Endometriosis: A Narrative Review of Therapeutic Approaches and Challenges The psychological dimension is not a separate problem layered on top of a physical one. Chronic pain and mental health interact bidirectionally: depression lowers pain thresholds, and uncontrolled pain worsens mood, creating a feedback loop that hormonal or surgical treatment alone cannot fully address. This is why integrated approaches that include psychological support alongside medical treatment tend to produce better outcomes.
Physical Therapy as a Complementary Approach
Endometriosis frequently causes secondary musculoskeletal problems. Chronic pelvic pain leads to guarding and tension in the pelvic floor muscles, altered posture, and restricted movement patterns that can persist even after the disease itself is treated. Physiotherapy aimed at endometriosis incorporates manual therapy including visceral mobilization, pelvic floor work, and exercise programs designed to reduce inflammation and restore mobility. The evidence base is still building, but physical therapy is increasingly recognized as a valuable complement to gynecological treatment for reducing pain and improving quality of life in people living with the disease.
Endometriosis in non-human species is almost exclusively observed in menstruating old-world primates, a detail that underscores how deeply the disease is linked to the biology of menstruation itself.29PubMed Central. Induced endometriosis in nonhuman primates Primate models have been instrumental in studying disease mechanisms precisely because these animals share the hormonal cycles and anatomy that make endometriosis possible. For most of the animal kingdom, which does not menstruate, the disease simply does not occur. That evolutionary quirk is a reminder that endometriosis is not a malfunction of the body so much as a vulnerability built into the particular way primate reproduction works.